BioStem Technologies, Inc. (BSEM) Misses Q1 EPS by 24c

BioStem Technologies, Inc. (OTC: BSEM) reported Q1 EPS of $0.27, $0.24 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $72.53 million versus the consensus estimate of $82.5 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low
• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'